Status: Not yet recruiting
Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma
Neoadjuvant RBP-01 in patients with primary uveal melanoma.
Participants needed: 30
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: ReBio PharmaUpdated: Aug 5, 2026
Eligibility criteria
Male and female participants aged ≥18 years. [+5]
Participant has received previous treatment with a PKC inhibitor at any time. [+6]